| Dr Jorge O Colon Balaguer, | |
|
131 Calle 2, Guaynabo, PR 00965-5803 | |
| (787) 946-4664 | |
| Not Available |
| Full Name | Dr Jorge O Colon Balaguer |
|---|---|
| Gender | Male |
| Speciality | Chiropractor |
| Location | 131 Calle 2, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134878010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 814 (Puerto Rico) | Primary |
| Provider Name | Discal Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437710407 PECOS PAC ID: 4981939683 Enrollment ID: O20190717003546 |
News Archive
Researchers in the United States have conducted a study showing that anti-sense agents called peptide-conjugated morpholino oligomers (PPMOs) have the ability to specifically and potently suppress the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
SQI Diagnostics Inc. (TSX-V: SQD), a medical systems company focused on evolving laboratory-based biomarker testing, today announced that it closed its previously announced, brokered private placement (the "Private Placement") for gross proceeds of $6,594,786.
New York health officials have awarded $462 million to help 22 hospitals and five large public hospital systems statewide continue key services. The funds followed a federal agreement in April for New York to reinvest $8 billion in Medicaid savings to support hospital overhauls and expand primary medical care over five years. The goal is to reduce avoidable hospital use by 25 percent while helping financially struggling institutions shift to more primary and outpatient care (7/9).
By attaching specialized molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jorge O Colon Balaguer, Hc 1 Box 3387, Las Marias, PR 00670-9452 Ph: (787) 604-4343 | Dr Jorge O Colon Balaguer, 131 Calle 2, Guaynabo, PR 00965-5803 Ph: (787) 946-4664 |
News Archive
Researchers in the United States have conducted a study showing that anti-sense agents called peptide-conjugated morpholino oligomers (PPMOs) have the ability to specifically and potently suppress the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
SQI Diagnostics Inc. (TSX-V: SQD), a medical systems company focused on evolving laboratory-based biomarker testing, today announced that it closed its previously announced, brokered private placement (the "Private Placement") for gross proceeds of $6,594,786.
New York health officials have awarded $462 million to help 22 hospitals and five large public hospital systems statewide continue key services. The funds followed a federal agreement in April for New York to reinvest $8 billion in Medicaid savings to support hospital overhauls and expand primary medical care over five years. The goal is to reduce avoidable hospital use by 25 percent while helping financially struggling institutions shift to more primary and outpatient care (7/9).
By attaching specialized molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
› Verified 4 days ago
Dr. Emanuel Echandy Rivera, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Buen Samaritano Street, Guaynabo, PR 00966 Phone: 787-792-3712 | |
Life Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: Urb. Ponce De Leon, 9 Ave Esmeralda, Guaynabo, PR 00969 Phone: 787-731-1575 Fax: 787-708-8481 | |
Paulina Barquero Sotomayor, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 11 Calle Carazo, Guaynabo, PR 00969 Phone: 787-998-5990 Fax: 787-998-5993 | |
Revive Quiropractica, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 11 Calle Carazo, Guaynabo, PR 00969 Phone: 787-430-5357 | |
Dr. Andre Jose Marquez, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 100 Carr. 165 Centro Internacional De Comercio, Suite 303, Guaynabo, PR 00968 Phone: 404-917-7775 Fax: 787-277-0847 | |
Grupo Quiropractico De Guaynabo Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Plaza Real Shopping Center Ave Arbolote 1, Suite 210, Guaynabo, PR 00971 Phone: 787-999-6570 Fax: 787-999-6571 |